+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery



Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery



Drug Design and Delivery 6(1): 1-13



In this review, phosphoinositide metabolism is discussed and potential sites for therapeutic intervention are identified. The rapid recent progress in several branches of inositol chemistry has greatly improved our knowledge of the structural requirements for recognition by a variety of key enzymes involved in the pathways, and by the physiological receptor for D-myo-inositol 1,4,5-trisphosphate. Based on existing leads, drug opportunities arise in reducing polarity, in the utilisation of apolar pro-drugs, and in the development of innovative intracellular delivery systems. The identification of novel pharmacophores for future exploration is likely.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040456134

Download citation: RISBibTeXText

PMID: 1964051


Related references

Neomycin: a specific drug to study the inositol-phospholipid signalling system?. Febs Letters 197(1-2): 285-288, 1986

Orphan nuclear receptors New hormone signalling pathways and drug discovery opportunities. Abstracts of Papers American Chemical Society 221(1-2): MEDI 179, 2001

Inositol phospholipid turnover in PAF transmembrane signalling. Lipids 26(12): 1028-1033, 1991

Regulatory role of retinoic acid on cultured mouse keratinocyte inositol phospholipid metabolism: dose-dependent release of inositol triphosphate. Journal of Investigative Dermatology 92(1): 72-77, 1989

Physical chemical drug-drug interactions from drug discovery to registration: new opportunities for the pharmaceutical scientist to impact drug development. Molecular Pharmaceutics 10(11): 3967-3969, 2013

Modulation of inositol phospholipid signalling in human breast cancer cells by protein kinase c. Journal of Endocrinology 124(Suppl.), 1990

Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells. Drug Discovery Today 12(15-16): 611-621, 2007

Inositol phospholipid metabolism in Arabidopsis. Characterized and putative isoforms of inositol phospholipid kinase and phosphoinositide-specific phospholipase C. Plant Physiology 130(1): 22-46, 2002

Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochemical Journal 293: 835-842, 1993

Modern drug discovery technologies: opportunities and challenges in lead discovery. Combinatorial Chemistry and High Throughput Screening 14(10): 830-839, 2011

Evidence that stomatin-induced differentiation in Tetrahymena vorax is mediated by signalling through rapid inositol phospholipid turnover. Journal of Eukaryotic Microbiology 44(1): 10A, 1997

Inositol lipid-mediated cellular signalling. Carbohydrate Research 234: Xi-Xxi, 1992

Cellular signalling in the kidney: the role of inositol lipids. Renal Physiology and Biochemistry 12(1): 1-31, 1989

Inositol lipids integration of cellular signalling systems. Putney, J W , Jr (Ed ) Receptor Biochemistry And Methodology, Vol 7 Phosphoinositides And Receptor Mechanisms Xi+400p Alan R Liss, Inc : New York, New York, Usa Illus 109-148, 1986, 1987